4-Guanidino-n-butyl Syringate (leonurine, SCM 198) Protects H9c2 Rat Ventricular Cells from Hypoxia-induced Apoptosis

Xin-hua Liu,Pei-fang Chen,Li-long Pan,Ranil De Silva,Yi-zhun Zhu
DOI: https://doi.org/10.1097/fjc.0b013e3181bae160
IF: 3.271
2009-01-01
Journal of Cardiovascular Pharmacology
Abstract:In the present study, we examined the ability of a chemically synthesized compound based on the structure of leonurine, a phytochemical component of Herba leonuri, to protect H9c2 rat ventricular cells from apoptosis induced by hypoxia and serum deprivation, as a model of ischemia. The results revealed a concentration-dependent increase in cell viability associated with leonurine treatment, accompanied by a consistent decline in lactate dehydrogenase leakage into the culture medium. The fraction of annexin V-fluorescein isothiocyanate-positive cells was increased by hypoxia but reduced by leonurine. These changes were associated with increased expression of the antiapoptotic gene, Bcl-2, and reduced expression of the proapoptotic gene, Bax. Leonurine also reduced the cytosolic Ca2+ overload induced by hypoxia. These results suggest that leonurine elicits potent cardioprotective effects in H9c2 cells, and these effects may be mediated by inhibition of intracellular Ca2+ overload and apoptosis during hypoxia.
What problem does this paper attempt to address?